MSS27 Clozapine-induced gastrointestinal hypomotility (CIGH)
This MSS guides staff to manage this risk associated with Clozapine which may impair motility of the entire gastrointestinal system.
We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use tewv.nhs.uk, remember your settings and improve our services.
We also use cookies set by other sites to help us deliver content from their services.
We know that some of our PDF documents may not be accessible to everyone but we’re working on it. As documents come up for renewal we aim to make them more accessible. In the meantime, if you need any of our policies in a different format please email [email protected]
This MSS guides staff to manage this risk associated with Clozapine which may impair motility of the entire gastrointestinal system.
Category: Medication Safety Series
Topic: Pharmacy
Clozapine Medication Safety Series
Category: Medication Safety Series
Topic: Pharmacy
Clozapine - processes for prescribing dispensing supply and monitoring
Category: Procedures
Topic: Pharmacy
Safety guidance information sheet for General practitioner for clozapine.
Category: Procedures
Topic: Pharmacy
The purpose of this safety guidance is to highlight key issues to be considered when patients who are taking clozapine are admitted to an acute hospital.
Category: Guidance
Topic: Pharmacy
This procedure outlines the clozapine dosage and how it should primarily be adjusted according to clinical response and patient tolerability of adverse effects.
Category: Procedures
Topic: Pharmacy